Conditional Pten knock-out mice: A model for metastatic phaeochromocytoma

Journal of Pathology

Volumn 217, Issue 4, 2009, Pages 597-604

  Korpershoek, Esther ^a   Loonen, Anne J M ^a   Corvers, Suzanne ^a   Van Nederveen, Francien H ^a   Jonkers, Jos ^b   Ma, Xiaoqian ^a   Van Der Made, Angelique Ziel ^a   Korsten, Hanneke ^a   Trapman, Jan ^a   Dinjens, Winand N M ^a   De Krijger, Ronald R ^a,c  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Adrenal gland; Array comparative genomic hybridization; Malignant; Mouse; Phaeochromocytoma; Pten

Indexed keywords

CRE RECOMBINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE SYNTHESIS; CHROMOSOME 11Q; CHROMOSOME 15; CHROMOSOME 19; CHROMOSOME 3P; CHROMOSOME 5; CHROMOSOME 6; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LUNG METASTASIS; MALE; METASTASIS; MOUSE; NONHUMAN; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; ADRENAL TUMOR; ANIMAL; DISEASE MODEL; DNA MICROARRAY; GENETICS; LUNG TUMOR; METABOLISM; MOUSE MUTANT; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADRENAL GLAND NEOPLASMS; ANIMALS; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHEOCHROMOCYTOMA; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PTEN PHOSPHOHYDROLASE;

EID: 62849112395     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2492     Document Type: Article

References (39)

1. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromo cytoma. Lancet 2005;366:665-675.
2. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhin ney SR, Muresan M, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene muta tions. J Am Med Assoc 2004;292:943- 951.
3. Koch CA, Pacak K, Chrousos GP. The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. J Clin Endocrinol Metab 2002;87:5367-5384.
4. Powers JF, Evinger MJ, Tsokas P, Bedri S, Alroy J, Shah savari M, et al. Pheochromocytoma cell lines from het erozygous neurofibromatosis knockout mice. Cell Tissue Res 2000;302:309-320.
5. Bai F, Pei XH, Pandolfi PP, Xiong Y. pl8 Ink4c and Pten constrain a positive regulatory loop between cell growth and cell cycle control. Mol Cell Biol 2006;26:4564-4576.
6. Di Cristofano A, de Acetis M, Koff A, Cordon-Cardo C, Pandolfi PP. Pten and p27KIPl cooperate in prostate cancer tumor suppression in the mouse. Nature Genet 2001;27:222-224.
7. You MJ, Castrillon DH, Bastian BC, O'Hagan RC, Bosen berg MW, Parsons R, et al. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice. Proc Natl Acad Sci U S A 2002;99:1455-1460.
8. Dannenberg JH, Schuijff L, Dekker M, van der Valk M, te Riele H. Tissue-specific tumor suppressor activity of retinoblastoma gene homologs pl07 and pl30. Genes Dev 2004;18:2952-2962.
9. Nikitin AY, Juarez-Perez MI, Li S, Huang L, Lee WH. RB- mediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb+/- mice. Proc Natl Acad Sci U S A 1999;96:3916-3921.
10. Franklin DS, Godfrey VL, O'Brien DA, Deng C, Xiong Y. Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol 2000;20:6147-6158.
11. Dahia PL. PTEN, a unique tumor suppressor gene. Endocr Relat Cancer 2000;7:115-129.
12. Di Cristofano A, Pandolfi PP. The multiple roles of PTEN in tumor suppression. Cell 2000;100:387-390.
13. van Nederveen FH, Perren A, Dannenberg H, Petri BJ, Din jens WN, Komminoth P, et al. PTEN gene loss, but not muta tion, in benign and malignant phaeochromocytomas. J Pathol 2006;209:274-280.
14. Stambolic V, Tsao MS, Macpherson D, Suzuki A, Chapman WB, Mak TW. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. Cancer Res 2000;60:3605-3611.
15. Cascon A, Ruiz-Llorente S, Rodriguez-Perales S, Honrado E, Martinez-Ramirez A, Leton R, et al. A novel candidate region linked to development of both pheochromocytoma and head/neck paraganglioma. Genes Chromosomes Cancer 2005;42:260-268.
16. Dannenberg H, Speel EJ, Zhao J, Saremaslani P, van Der Harst E, Roth J, et al. Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas. Am J Pathol 2000;157:353-359.
17. Edstrom E, Mahlamaki E, Nord B, Kjellman M, Karhu R, Hoog A, et al. Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology. Am J Pathol 2000;156:651-659.
18. Koch CA, Huang SC, Zhuang Z, Stolle C, Azumi N, Chrousos GP, et al. Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma. Oncogene 2002;21:479-482.
19. Powers JF, Tischler AS, Mohammed M, Naeem R. Microarraybased comparative genomic hybridization of pheochromocytoma cell lines from neurofibromatosis knockout mice reveals genetic alterations similar to those in human pheochromocytomas. Cancer Genet Cytogenet 2005;159:27-31.
20. Ma X, Ziel-van Der Made AC, Autar B, van Der Korput HA, Vermeij M, van Duijn P, et al. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis. Cancer Res 2005;65:5730-5739.
21. Korpershoek E, Leenen PJ, Drexhage HA, de Krijger RR. Cellular composition of pancreas-associated lymphoid tissue during human fetal pancreatic development. Histopathology 2004;45:291-297.
22. Vargas SO, Korpershoek E, Kozakewich HP, de Krijger RR, Fletcher JA, Perez-Atayde AR. Cytogenetic and p53 profiles in congenital cystic adenomatoid malformation: insights into its relationship with pleuropulmonary blastoma. Pediatr Dev Pathol 2006;9:190-195.
23. Chung YJ, Jonkers J, Kitson H, Fiegler H, Humphray S, Scott C, et al. A whole-genome mouse BAC microarray with 1-Mb resolution for analysis of DNA copy number changes by array comparative genomic hybridization. Genome Res 2004;14:188-196.
24. Cleutjens KB, van Der Korput HA, Ehren-van Eekelen CC, Sikes RA, Fasciana C, Chung LW, et al. A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans. Mol Endocrinol 1997;11:1256-1265.
25. Schulz N, Propst F, Rosenberg MP, Linnoila RI, Paules RS, Kovatch R, et al. Pheochromocytomas and C-cell thyroid neoplasms in transgenic c-mos mice: a model for the human multiple endocrine neoplasia type 2 syndrome. Cancer Res 1992;52:450-455.
26. Tischler AS, Shih TS, Williams BO, Jacks T. Characterization of pheochromocytomas in a mouse strain with a targeted disruptive mutation of the neurofibromatosis gene Nf1. Endocr Pathol 1995;6:323-335.
27. Fassnacht M, Weismann D, Ebert S, Adam P, Zink M, Beuschlein F, et al. AKT is highly phosphorylated in pheochromocytomas but not in benign adrenocortical tumors. J Clin Endocrinol Metab 2005;90:4366-4370.
28. Ni Y, Zbuk KM, Sadler T, Patocs A, Lobo G, Edelman E, et al. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. Am J Hum Genet 2008;83:261-268.
29. Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, et al. Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 2005;23:8812-8818.
30. Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, et al. Clinical presentation and penetrance of pheochromocytoma/ paraganglioma syndromes. J Clin Endocrinol Metab 2006;91:827-836.
31. Cascon A, Ruiz-Llorente S, Cebrian A, Leton R, Telleria D, Benitez J, et al. G12S and H50R variations are poly morphisms in the SDHD gene. Genes Chromosomes Cancer 2003;37:220-221.
32. Korpershoek E, Petri BJ, van Nederveen FH, Dinjens WN, Verhofstad AA, de Herder WW, et al. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma. Endocr Relat Cancer 2007;14:453-462.
33. Gnarra JR, Ward JM, Porter FD, Wagner JR, Devor DE, Grinberg A, et al. Defective placental vasculogenesis causes embry onic lethality in VHL-deficient mice. Proc Natl Acad Sci U S A 1997;94:9102-9107.
34. Hasegawa T, Enomoto A, Kato T, Kawai K, Miyamoto R, Jijiwa M, et al. Roles of induced expression of MAPK phosphatase-2 in tumor development in RET-MEN2A trans genicmice. Oncogene 2008;27:5684-5695.
35. Ortega-Saenz P, Pascual A, Piruat JI, Lopez-Barneo J. Mecha nisms of acute oxygen sensing by the carotid body: lessons from genetically modified animals. Respir Physiol Neurobiol 2007;157:140-147.
36. Hering A, Guratowska M, Bucsky P, Claussen U, Decker J, Ernst G, et al. Characteristic genomic imbalances in pediatric pheochro mocytoma. Genes Chromosomes Cancer 2006;45:602-607.
37. Elder EE, Xu D, Hoog A, Enberg U, Hou M, Pisa P, et al. KI-67 and hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma. Mod Pathol 2003;16:246-255.
38. Isobe K, Yashiro T, Omura S, Kaneko M, Kaneko S, Kamma H, et al. Expression of the human telomerase reverse transcriptase in pheochromocytoma and neuroblastoma tissues. Endocr J 2004;51:47-52.
39. Ubink R, Lange W, Verhofstad A. Simultaneous immunoenzymatic staining of catecholamines, catecholamine-biosynthesizing enzymes, and bromodeoxyuridine in adrenal medullary cells of the rat. J Histochem Cytochem 1995;43:39-46.